Elephas

Elephas

Private
Madison, WisconsinHealthcare & Life Scienceshttps://www.elephas.com

Last Round

Series B

Extension

Nov 6, 2025

Total Funding Raised

$164.5M

Momentum Score

25 /100

Company Overview

Elephas is a healthcare and biotechnology company that specializes in live tumor imaging diagnostics to personalize cancer therapy for patients using advanced technologies in cancer biology, microscopy, engineering, and artificial intelligence.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Drug Discovery, Clinical Trials, Medical AI

Business Model

B2B

Customer Profile

Services & Consulting, Hardware + Subscription, Data as a Service

AI Layer

Application

Keywords

ex vivo diagnosticsimmunotherapy response predictionlive tumor diagnosticsfunctional precision medicinetumor microenvironmentoncology diagnosticsTMElive tissue analysisbiopharma servicesprecision medicineimmuno-oncologydrug discovery servicespredictive diagnosticspatient stratificationclinical trial servicesmedical AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Elephas Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Elephas Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series B ExtensionNov 6, 2025
Series CJan 23, 2024
Series BSep 6, 2022

Key People

Founding team and executive leadership

Maneesh Arora

Chief Executive Officer

Executive Team

Terry Brady

Chief Financial Officer

Executive Team

Elephas Investors

Notable investors and investment history

InvestorRounds
ARCH Venture PartnersSeries B Extension
WARF VenturesSeries A, Series C, Series B
State of Wisconsin Investment BoardSeries B Extension, Series C
Northpond VenturesSeries B Extension
Moore Strategic VenturesSeries C, Series B
Venture Investors Health FundSeries B Extension, Series C
ARCH Venture PartnersSeries B Extension, Series C, Series B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 15, 2026

    Partnering with Mithrl to accelerate research using their AI platform.

  • Feb 1, 2026

    Partnering with the University of Louisville on cancer therapy research.

Elephas Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Elephas Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Elephas's valuation, stock price, and market status.

Firmographic Details

HeadquartersMadison, Wisconsin
Employee Range137
Year Founded2020
Last FundingNov 6, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.